Data resources for post-marketing surveillance of nonmedical use of pharmaceuticals and use of illicit drug substances
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75F40121D00033
- Awardee
-
Denver Health And Hospital Authority UEI MMT4LGM4H9Z5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 6 $2,023,889 obligated
Award facts
- Opportunity
-
- FDARFP1243229 Solicitation number
- Combined order value
-
- $2,023,889 Current, with exercised options
- $2,186,159 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 20% used
- $10,000,000.00
- Maximum order
- $10,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award, valued up to $10 million, was issued by the U.S. Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a U.S. local/state government entity and healthcare provider. The contract provides data resources to support the FDA's post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug use.
Under this IDV, Denver Health has been awarded multiple firm fixed-price delivery orders. These include a $205,010 contract for a survey on nonmedical use of prescription drugs, a $630,211 contract for an online panel survey to assess the prevalence and experiences of falsified/unapproved pharmaceuticals, and a $695,889 contract for broader data collection and analytics services to support the FDA's pharmaceutical safety surveillance programs. The contracts do not have any set-aside designations and will be performed in Denver, Colorado and Silver Spring, Maryland through September 2024, 2025, and 2026 respectively. Denver Health, as a major healthcare provider serving underserved populations, has significant expertise in public health data initiatives and federal contracting across the Department of Health and Human Services.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75F40121D00033?
75F40121D00033 was awarded to Denver Health And Hospital Authority by Food and Drug Administration (Department of Health and Human Services) on September 27, 2021.
How much is contract 75F40121D00033 worth?
Orders under 75F40121D00033 have obligated $2,023,889. Their combined potential value, with all options, is $2,186,159. 75F40121D00033's own ceiling is $10,000,000. A single order can be worth up to $10,000,000.
How many orders have been placed under contract 75F40121D00033?
6 orders have been placed under 75F40121D00033, the latest on September 30, 2026.
Who can order from contract 75F40121D00033?
75F40121D00033 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75F40121D00033 competed?
The extent of competition for 75F40121D00033 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV